Ergotamine Mesylate Tablets
Function and Efficacy
Animal experiments have shown that dihydroergoline mesylate changes brain neurotransmission, and data show that it has an agonist effect on dopamine and 5-hydroxytryptamine receptors and a blocker effect on α-adrenaline receptors. It improves damaged brain metabolic function and shortens brain circulation time. This effect is reflected in changes in brain electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG).
Ingredients
The main ingredient of this product is dihydroergoline mesylate, which is composed of equal amounts of dihydroergoline mesylate, dihydroergocrine mesylate, and dihydroergocrine mesylate [dihydro-α-ergocrine mesylate: dihydro-β-ergocrine mesylate (2:1)].
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Dihydroergotoxine mesylateIngredients |
It changes the brain's neurotransmission, has an agonist effect on dopamine and 5-hydroxytryptamine receptors, a blocking effect on α-adrenaline receptors, improves damaged brain metabolic function, and shortens cerebral circulation time. This effect is reflected in changes in the brain's electrical activity, with significant changes in the power spectrum of the electroencephalogram (EEG). More |
8067-24-1 | 12 |
Indication
1. Mainly used to improve the symptoms and physical signs of mental degeneration related to aging; 2. Symptoms of functional and intellectual decline caused by acute and chronic cerebrovascular diseases; 3. Mild to moderate vascular dementia; 4. Vascular headache;
Usage and Dosage
Oral administration: 1-2 mg at a time, 3-6 mg per day; take before meals, and follow the doctor's advice for the course of treatment.
Adverse Reactions
Occasionally, nasal congestion, short-term nausea and discomfort may occur, but this can usually be avoided by taking the drug with food. In most cases, no special measures are required and the side effects disappear. The dosage can be adjusted if necessary.
Precautions
1. Patients with a history of allergy to this product are prohibited from using it; 2. Patients with severe heart disease, especially those with bradycardia, should not use it; 3. Pregnant women should use it with caution.
Special Population Medication
Precautions during pregnancy and lactation: Use with caution in pregnant women.
Drug Interactions
(1) When used in combination with cyclosporine, the pharmacokinetics of cyclosporine will be altered. (2) When dopamine is used in combination with dihydroergotamine, it can induce peripheral vasospasm, especially vasoconstriction of distal limbs.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
1mg
Manufacturer
Yangzhou Ilyang Pharm. Co., Ltd.
-
Founded in:
2002-02-10 -
Address:
No. 8 Changxing Road, Gaoyou City -
Tax NO.:
913210846087092887 -
Registered Funds:
$6.25 million -
Website:
-
Email: